You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sargramostim

Showing 51 - 75 of 536
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States

Recruiting
  • Breast Adenocarcinoma
  • +7 more
  • Multi-epitope HER2 Peptide Vaccine TPIV100
  • +5 more
  • Scottsdale, Arizona
  • +26 more
Aug 17, 2022

Neuroblastoma Trial in New York (anti-GD2 murine IgG3 mAb 3F8)

Completed
Has Results
  • Neuroblastoma
  • anti-GD2 murine IgG3 monoclonal antibody 3F8
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Apr 21, 2022

Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma, Stage IB Breast Cancer AJCC v7 Trial in United States (drug, other,

Active, not recruiting
  • Bilateral Breast Carcinoma
  • +11 more
  • Scottsdale, Arizona
  • +11 more
Jan 12, 2023

Cytomegalovirus Retinitis, HIV Trial in United States (Zidovudine, Sargramostim, Ganciclovir)

Completed
  • Cytomegalovirus Retinitis
  • HIV Infections
  • Los Angeles, California
  • +3 more
Oct 28, 2021

HIV Trial in San Diego, Aurora, Indianapolis (Indinavir sulfate, Lamivudine/Zidovudine, Hepatitis A Vaccine (Inactivated))

Completed
  • HIV Infections
  • Indinavir sulfate
  • +6 more
  • San Diego, California
  • +2 more
Oct 27, 2021

HIV Trial in United States (APL 400-047, ALVAC-HIV MN120TMG (vCP205), Sargramostim)

Completed
  • HIV Infections
  • APL 400-047
  • +2 more
  • Birmingham, Alabama
  • +3 more
Oct 28, 2021

Metastatic Cancer Trial in Scottsdale (Keytruda Injectable Product, Yervoy Injectable Product, GM-CSF)

Recruiting
  • Metastatic Cancer
  • Keytruda Injectable Product
  • +3 more
  • Scottsdale, Arizona
    Vincere Cancer Center
Feb 8, 2021

Stage IB Melanoma, Stage IIA Melanoma, Stage IIB Melanoma Trial in Los Angeles (biological, procedure, other)

Withdrawn
  • Stage IB Melanoma
  • +3 more
  • sargramostim
  • +3 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Jul 23, 2020

Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in San Francisco (Ipilimumab, Laboratory Biomarker

Completed
  • Recurrent Prostate Carcinoma
  • Stage IV Prostate Cancer AJCC v7
  • Ipilimumab
  • +3 more
  • San Francisco, California
    UCSF Medical Center-Mount Zion
Jul 29, 2020

Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI

Completed
Has Results
  • Myelodysplastic Syndrome (MDS)
  • +2 more
  • WT1:126-134
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021

Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)

Active, not recruiting
  • Ganglioneuroblastoma, Nodular
  • Neuroblastoma
  • Dinutuximab
  • +4 more
  • Mesa, Arizona
  • +77 more
Aug 17, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Aldesleukin
  • +9 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)

Active, not recruiting
  • Hodgkin's Lymphoma
  • +17 more
  • mycophenolate mofetil
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Dec 21, 2021

Head and Neck Squamous Cell Carcinoma Trial in Germany (UV1, Sargramostim for Injection, Pembrolizumab injection)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • UV1
  • +2 more
  • Aachen, Germany
  • +9 more
Mar 8, 2022

High Risk Neuroblastoma Trial in United States (biological, other, drug)

Completed
Has Results
  • High Risk Neuroblastoma
  • Aldesleukin
  • +4 more
  • Loma Linda, California
  • +31 more
Jul 30, 2021

HER2/Neu Negative, No Evidence of Disease, One or More Positive Axillary Nodes Trial in Seattle, Madison (Laboratory Biomarker

Active, not recruiting
  • HER2/Neu Negative
  • +10 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
  • +1 more
Jan 11, 2022

Breast Cancer Trial in United States (NeuVax vaccine, Trastuzumab, GM-CSF)

Completed
  • Breast Cancer
  • NeuVax vaccine
  • +2 more
  • Santa Monica, California
  • +23 more
Sep 15, 2022

Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8 Trial

Not yet recruiting
  • Anatomic Stage IB Breast Cancer AJCC v8
  • +16 more
  • CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
  • Sargramostim
  • Seattle, Washington
  • +1 more
Jul 27, 2022

Ovarian Cancer, Endometrial Cancer, Fallopian Cancer Trial in Annandale (E39 peptide (100mcg)/GM-CSF vaccine plus E39 booster,

Completed
  • Ovarian Cancer
  • +3 more
  • E39 peptide (100mcg)/GM-CSF vaccine plus E39 booster
  • +6 more
  • Annandale, Virginia
    Mid-Atlantic Gynecologic Oncology & Pelvic Surgery Associates
Apr 28, 2020

Breast Cancer Trial in Philadelphia (incomplete Freund's adjuvant, sargramostim, telomerase: 540-548 peptide vaccine)

Completed
  • Breast Cancer
  • incomplete Freund's adjuvant
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Feb 3, 2020

Lymphoma, Non-Hodgkin, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)

Completed
  • Lymphoma, Non-Hodgkin
  • HIV Infections
  • Bleomycin sulfate
  • +9 more
  • Los Angeles, California
  • +21 more
Oct 26, 2021

Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma Trial in Worldwide

Active, not recruiting
Has Results
  • Localized Resectable Neuroblastoma
  • +5 more
  • Aldesleukin
  • +6 more
  • Birmingham, Alabama
  • +196 more
Dec 30, 2022

Hereditary Pulmonary Alveolar Proteinosis Trial in Cincinnati, Richmond (Leukine)

Completed
Has Results
  • Hereditary Pulmonary Alveolar Proteinosis
  • Cincinnati, Ohio
  • +1 more
Aug 31, 2020

Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

Recruiting
  • Medulloblastoma
  • +7 more
  • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
  • +2 more
  • Buffalo, New York
  • +2 more
Jul 8, 2022

Breast Cancer, Ovarian Cancer Trial in Houston (E39 peptide vaccine, E39 vaccine then J65 vaccine, J65 vaccine then E39 vaccine)

Completed
  • Breast Cancer
  • Ovarian Cancer
  • E39 peptide vaccine
  • +2 more
  • Houston, Texas
    University of Texas M.D. Anderson Cancer Center
Mar 16, 2020